TY - JOUR
T1 - Hospital-based sentinel surveillance for bacterial meningitis in under-five children prior to the introduction of the PCV13 in India
AU - Jayaraman, Yuvaraj
AU - Veeraraghavan, Balaji
AU - Girish Kumar, C. P.
AU - Sukumar, Bharathy
AU - Rajkumar, Prabu
AU - Kangusamy, Boopathi
AU - Verghese, Valsan Philip
AU - Varghese, Rosemol
AU - Jayaraman, Ranjith
AU - Kapoor, Ambujam Nair
AU - Gupta, Nivedita
AU - Kanagasabai, K.
AU - David, Joseph K.
AU - Rajaraman, Jayasri
AU - Sockalingam, Gowtham
AU - Khera, Ajay
AU - Haldar, Pradeep
AU - Aggarwal, M. K.
AU - Pillai, Rajamohanan K.
AU - Manchanda, Vikas
AU - Theodore, Ramani Bai Joseph
AU - Rajahamsan, Jyothi
AU - Mohan, Girija
AU - Jayalekshmi, V.
AU - Nedunchelian, Krishnamoorthy
AU - Devasena, N.
AU - Sridharan, Sujatha
AU - Selvi, R.
AU - Ravinder, T.
AU - Narayana Babu, R.
AU - Mathevan, G.
AU - Sugumari, C.
AU - Sugandhi Rao, P.
AU - Kini, Pushpa G.
AU - Dwibedi, Bhagirathi
AU - Kanga, Anil
AU - Grover, Neelam
AU - Narayanan, Harish
AU - Mehendale, Sanjay M.
N1 - Funding Information:
This study was supported by a grant from Ministry of Health and Family Welfare, Government of India [Grant No: G.27017/02/2011-CC&V].
Publisher Copyright:
© 2021 The Authors
PY - 2021/6/23
Y1 - 2021/6/23
N2 - Introduction: A hospital-based sentinel surveillance network for bacterial meningitis was established in India to estimate the burden of bacterial meningitis, and the proportion of major vaccine-preventable causative organisms. This report summarises the findings of the surveillance conducted between March 2012, and September 2016 in eleven hospitals. Methods: We enrolled eligible children with bacterial meningitis in the age group of one to 59 months. CSF samples were collected and processed for biochemistry, culture, latex agglutination, and real-time PCR. Pneumococcal isolates were serotyped and tested for antimicrobial susceptibility. Results: Among 12 941 enrolled suspected meningitis cases, 586 (4.5%) were laboratory confirmed. S. pneumoniae (74.2%) was the most commonly detected pathogen, followed by H. influenzae (22.2%), and N. meningitidis (3.6%). Overall 58.1% of confirmed bacterial meningitis cases were children aged between one, and 11 months. H. influenzae meningitis cases had a high (12.3%) case fatality rate. The serotypes covered in PCV13 caused 72% pneumococcal infections, and the most common serotypes were 14 (18.3%), 6B (12.7%) and 19F (9.9%). Non-susceptibility to penicillin was 57%. Forty-five (43.7%) isolates exhibited multidrug resistance, of which 37 were PCV13 serotype isolates. Conclusions: The results are representative of the burden of bacterial meningitis among under-five children in India. The findings were useful in rolling out PCV in the National Immunization Program. The non-susceptibility to penicillin and multidrug resistance was an important observation. Timely expansion of PCV across India will significantly reduce the burden of antimicrobial resistance. Continued surveillance is needed to understand the trend after PCV expansion in India.
AB - Introduction: A hospital-based sentinel surveillance network for bacterial meningitis was established in India to estimate the burden of bacterial meningitis, and the proportion of major vaccine-preventable causative organisms. This report summarises the findings of the surveillance conducted between March 2012, and September 2016 in eleven hospitals. Methods: We enrolled eligible children with bacterial meningitis in the age group of one to 59 months. CSF samples were collected and processed for biochemistry, culture, latex agglutination, and real-time PCR. Pneumococcal isolates were serotyped and tested for antimicrobial susceptibility. Results: Among 12 941 enrolled suspected meningitis cases, 586 (4.5%) were laboratory confirmed. S. pneumoniae (74.2%) was the most commonly detected pathogen, followed by H. influenzae (22.2%), and N. meningitidis (3.6%). Overall 58.1% of confirmed bacterial meningitis cases were children aged between one, and 11 months. H. influenzae meningitis cases had a high (12.3%) case fatality rate. The serotypes covered in PCV13 caused 72% pneumococcal infections, and the most common serotypes were 14 (18.3%), 6B (12.7%) and 19F (9.9%). Non-susceptibility to penicillin was 57%. Forty-five (43.7%) isolates exhibited multidrug resistance, of which 37 were PCV13 serotype isolates. Conclusions: The results are representative of the burden of bacterial meningitis among under-five children in India. The findings were useful in rolling out PCV in the National Immunization Program. The non-susceptibility to penicillin and multidrug resistance was an important observation. Timely expansion of PCV across India will significantly reduce the burden of antimicrobial resistance. Continued surveillance is needed to understand the trend after PCV expansion in India.
UR - http://www.scopus.com/inward/record.url?scp=85107141698&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85107141698&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2021.05.041
DO - 10.1016/j.vaccine.2021.05.041
M3 - Article
AN - SCOPUS:85107141698
SN - 0264-410X
VL - 39
SP - 3737
EP - 3744
JO - Vaccine
JF - Vaccine
IS - 28
ER -